The Nigeria Centre for Disease Control in its ‘National Strategy to Scale Up Access to Coronavirus Disease Testing in Nigeria’ posted on its website noted that the objective of planning to repurpose the tuberculosis machines were to decentralise and speed up testing across the country and strengthen national surveillance for COVID-19.
In the document, the NCDC explained that the country has 407 GeneXpert instruments deployed in 399 health facilities across the country, for use as first-line testing for TB diagnosis. It, however, noted that the United States-based Food and Drug Administration had granted the manufacturer, Cepheid, Emergency Use Authorisations for the use of the instruments and specially designed cartridge in testing for COVID-19.
The NCDC, which is the coordinating agency for the COVID-19 response in the country, said given that “every state of the federation including the FCT has at least five GeneXpert sites, at least one site in each state will be repurposed for COVID-19 testing.”
No comments:
Post a Comment